OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

Rhea-AI Summary

OPKO Health (Nasdaq: OPK) will participate in the Jefferies Biotech on the Beach Summit March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will hold one-on-one investor meetings on Wednesday, March 11. Investors should contact their Jefferies representative to schedule meetings.

Market Context

This announcement highlights OPKO’s continued engagement with the investor community via the Jefferi...

Analysis

This announcement highlights OPKO’s continued engagement with the investor community via the Jefferies Biotech on the Beach Summit on March 10–11, 2026, including one-on-one meetings on March 11. It follows a series of conference appearances, partnership expansions and asset sales outlined in recent news and SEC filings. Investors evaluating this type of event-driven update have often focused on how it connects back to financial performance, pipeline milestones and execution on previously disclosed strategic transactions.

Key Figures

Summit dates: March 10–11, 2026

1 metrics

Summit dates March 10–11, 2026 Jefferies Biotech on the Beach Summit schedule

Historical Context

5 past events · Latest: Feb 12 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 12	Earnings date notice	Neutral	-3.2%	Announced timing for Q4 2025 financial results and conference call logistics.
Feb 04	Partnership expansion	Positive	-0.8%	Expanded Entera Bio collaboration on oral LA-PTH and OXM programs with shared costs.
Jan 06	Conference participation	Neutral	+3.0%	Participation in J.P. Morgan Healthcare Conference with 1:1 meetings and fireside chat.
Nov 19	Conference participation	Neutral	-0.8%	Appearance at Piper Sandler Healthcare Conference with one-on-one investor meetings.
Oct 29	Earnings and deals	Positive	+2.1%	Reported Q3 2025 results, asset sale to Labcorp and large-scale Regeneron collaboration.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

OPKO’s event and partnership headlines have often seen mixed or muted price reactions, with one notable partnership update selling off despite seemingly positive strategic content.

Recent Company History

Over the past several months, OPKO has reported key financial updates and a series of strategic and investor-relations events. An earnings date announcement on Feb 12, 2026 saw a modest decline. A partnership expansion with Entera Bio on Feb 4, 2026 prompted a slight drop despite positive collaboration details. Participation in major healthcare conferences in Jan 2026 and Dec 2025 produced small, mixed moves. Q3 2025 results on Oct 29, 2025, featuring asset sales and profitability, were followed by a modest gain, suggesting select fundamentals-driven news has been better received.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will be holding one-on-one meetings with investors registered for the event on Wednesday, March 11^th.

Investors interested in scheduling a meeting with OPKO management should contact their Jefferies representative.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com

FAQ

When will OPKO (OPK) participate in the Jefferies Biotech on the Beach Summit?

OPKO will participate at the Jefferies Biotech on the Beach Summit March 10-11, 2026, with investor meetings March 11. According to the company, management will be on-site at 1 Hotel South Beach in Miami for scheduled one-on-one meetings with registered investors.

Where is OPKO (OPK) scheduled to meet investors during the March 2026 summit?

OPKO management will be at 1 Hotel South Beach in Miami during the March 10-11, 2026 summit. According to the company, one-on-one investor meetings are planned for Wednesday, March 11, for investors registered through the event.

How can investors schedule a meeting with OPKO (OPK) management at the March 11 event?

Investors should contact their Jefferies representative to schedule meetings with OPKO management for March 11. According to the company, meetings are available only to investors registered for the Jefferies Biotech on the Beach Summit.

Will OPKO (OPK) hold one-on-one meetings at Jefferies Biotech on the Beach and when?

Yes. OPKO will hold one-on-one investor meetings on Wednesday, March 11, 2026, at the summit. According to the company, these meetings are for investors registered with the Jefferies event and require scheduling through a Jefferies representative.

Who should investors contact to arrange a meeting with OPKO (OPK) at the March 2026 summit?

Investors should reach out to their Jefferies representative to arrange a meeting with OPKO management for March 11. According to the company, scheduling is managed by Jefferies for attendees registered at the Biotech on the Beach Summit.